ClinConnect ClinConnect Logo
Search / Trial NCT04119050

Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

Launched by JANSSEN RESEARCH & DEVELOPMENT, LLC · Oct 4, 2019

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Warm Autoimmune Hemolytic Anemia M281 (Nipocalimab) W Aiha Jnj 80202135

ClinConnect Summary

This clinical trial is studying a new treatment called M281 for adults with a condition known as warm autoimmune hemolytic anemia (wAIHA). This condition occurs when the body's immune system mistakenly attacks and destroys its own red blood cells, leading to anemia, which means not having enough healthy red blood cells to carry oxygen throughout the body. The main goal of the study is to see how effective and safe M281 is for people with this condition.

To participate in the trial, individuals must be at least 18 years old and have been diagnosed with wAIHA for at least three months. They should also be currently receiving treatment for this condition or have received treatment in the past. Unfortunately, pregnant or breastfeeding individuals cannot join the study, nor can those with certain other related blood disorders. Participants will have the opportunity to receive the new treatment and will be closely monitored by the research team throughout the trial. This is an important step in finding better ways to help manage wAIHA and improve the quality of life for those affected by it.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Participants greater than or equal to (\>=)18 years of age
  • Have been diagnosed with warm autoimmune hemolytic anemia (wAIHA) for at least 3 months, and are currently receiving treatment for wAIHA or have previously received treatment for wAIHA (treatment-naive participants are not eligible)
  • Participants must be able to understand and voluntarily provide written informed consent to participate in the study and comply with all study procedures
  • Exclusion criteria:
  • Participants must not be pregnant or breastfeeding
  • Participants must not have other clinically relevant abnormalities currently or in their history that the Investigator would deem them ineligible to participate
  • Have been diagnosed with cold antibody autoimmune hemolytic anemia (AIHA), cold agglutinin syndrome, mixed type (that is, warm and cold) AIHA, or paroxysmal cold hemoglobinuria

About Janssen Research & Development, Llc

Janssen Research & Development, LLC, a subsidiary of Johnson & Johnson, is a leading pharmaceutical company dedicated to advancing innovative therapies in multiple therapeutic areas, including oncology, immunology, neuroscience, infectious diseases, and cardiovascular health. With a strong commitment to scientific excellence and patient-centered research, Janssen leverages cutting-edge technology and collaborative partnerships to drive the development of transformative treatments. The company is focused on addressing unmet medical needs through rigorous clinical trials and a robust pipeline, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Los Angeles, California, United States

Philadelphia, Pennsylvania, United States

Durham, North Carolina, United States

Philadelphia, Pennsylvania, United States

New Orleans, Louisiana, United States

Vicenza, , Italy

Chicago, Illinois, United States

Brooklyn, New York, United States

Toronto, Ontario, Canada

Kansas City, Missouri, United States

Salt Lake City, Utah, United States

Pittsburgh, Pennsylvania, United States

Gainesville, Florida, United States

Madison, Wisconsin, United States

Tacoma, Washington, United States

Madrid, , Spain

Gainesville, Florida, United States

Oklahoma City, Oklahoma, United States

Greenville, North Carolina, United States

Tel Aviv, , Israel

Detroit, Michigan, United States

Amsterdam, , Netherlands

Eindhoven, , Netherlands

Seoul, , Korea, Republic Of

Groningen, , Netherlands

Fukushima, , Japan

Liverpool, , United Kingdom

Toyama, , Japan

Seoul, , Korea, Republic Of

Sendai, , Japan

Shanghai, , China

Tacoma, Washington, United States

Jerusalem, , Israel

Essen, , Germany

Poitiers, , France

Lake Success, New York, United States

Nyack, New York, United States

Kuala Lumpur, , Malaysia

Firenze, , Italy

Chengdu, , China

Alexandria, , Egypt

Ampang, , Malaysia

Suzhou, , China

Nanjing, , China

Yonago, , Japan

Riverside, California, United States

Praha 10, , Czechia

Alcalá De Henares, , Spain

Riverside, California, United States

Madrid, , Spain

Beer Sheva, , Israel

Mykolaiv, , Ukraine

Budapest, , Hungary

Jerusalem, , Israel

Brno, , Czechia

Whittier, California, United States

London, , United Kingdom

Berlin, , Germany

Den Haag, , Netherlands

Petach Tikvah, , Israel

Firenze, , Italy

Sao Paulo, , Brazil

Daegu, , Korea, Republic Of

Larissa, , Greece

Aurora, Colorado, United States

Salvador, , Brazil

Shanghai, , China

Changchun, , China

Firenze, , Italy

Maastricht, , Netherlands

Sao Paulo, , Brazil

Warszawa, , Poland

Majadahonda, , Spain

Kuantan, , Malaysia

La Tronche, , France

Glendale, Arizona, United States

Suita, , Japan

Kuching, , Malaysia

Debrecen, , Hungary

Miami Lakes, Florida, United States

Haifa, , Israel

Monza, , Italy

Canterbury, , United Kingdom

München, , Germany

Orlando, Florida, United States

Roma, , Italy

Nantong, , China

Aurora, Colorado, United States

Columbus, Ohio, United States

Wuhan, , China

Madrid, , Spain

Athens, , Greece

Opole, , Poland

Milan, , Italy

Xi'an, , China

Kaposvar, , Hungary

Daejeon, , Korea, Republic Of

Amiens, , France

Sao Paulo, , Brazil

Budapest, , Hungary

Madrid, , Spain

Madrid, , Spain

Málaga, , Spain

Wakayama, , Japan

Roma, , Italy

Tianjin, , China

Brescia, , Italy

Madrid, , Spain

Jacksonville, Florida, United States

Katowice, , Poland

Oxford, , United Kingdom

Badalona, , Spain

Barcelona, , Spain

Lanzhou, , China

London, , United Kingdom

Afula, , Israel

Ogaki, , Japan

Pamplona, , Spain

Johor Bahru, , Malaysia

Sao Paulo, , Brazil

Valencia, , Spain

Iruma Gun, , Japan

Xi'an, , China

Kecskemét, , Hungary

Nantes, , France

Sao Paulo, , Brazil

Palermo, , Italy

Córdoba, , Spain

Nyíregyháza, , Hungary

Brescia, , Italy

Buffalo, New York, United States

Bialystok, , Poland

Dijon, , France

Salvador, , Brazil

Budapest, , Hungary

Oxford, Oxfordshire, United Kingdom

Southampton, , United Kingdom

Brest Cedex 2, , France

Haikou, , China

Pozuelo De Alarcon, , Spain

Goiânia, , Brazil

Torino, , Italy

London, , United Kingdom

Netanya, , Israel

Cairo, , Egypt

Málaga, , Spain

Palma De Mallorca, , Spain

Catania, , Italy

Las Palmas De Gran Canaria, , Spain

Zaragoza, , Spain

Dnipro, , Ukraine

Sao Paulo, , Brazil

Liverpool, , United Kingdom

Niterói, , Brazil

Kyiv, , Ukraine

Catania, , Italy

Wuhan, , China

Novara, , Italy

Sapporo, , Japan

Cleveland, Ohio, United States

Santo André, , Brazil

Gyõr, , Hungary

Torino, , Italy

Vicenza, , Italy

Kanagawa, , Japan

Plymouth, , United Kingdom

Cairo, , Egypt

Boynton Beach, Florida, United States

Gainesville, Florida, United States

Hialeah, Florida, United States

Saint Petersburg, Florida, United States

Lake Success, New York, United States

Chapel Hill, North Carolina, United States

Greenville, North Carolina, United States

Laurinburg, North Carolina, United States

Belem, , Brazil

Botucatu, , Brazil

Goiania, , Brazil

Recife, , Brazil

Salvador, , Brazil

Sao Jose Do Rio Preto, , Brazil

Beijing Shi, , China

Beijing Shi, , China

Guangzhou Shi, , China

Hangzhou, , China

Shanghai, , China

Praha 2, , Czechia

Athens, , Greece

Athens, , Greece

Patras, , Greece

Thessaloniki, , Greece

Pécs, , Hungary

Jerusalem, , Israel

Ascoli Piceno, , Italy

Catania, , Italy

Milano, , Italy

Roma, , Italy

Kitakyusyu Shi, , Japan

Kofu Shi, , Japan

Nagoya Shi, , Japan

Sungai Buloh, , Malaysia

Gdansk, , Poland

Wałbrzych, , Poland

łódź, , Poland

Barcelona, , Spain

Burgos, , Spain

Málaga, , Spain

Cherkassy, , Ukraine

Kyiv, , Ukraine

Ternopil, , Ukraine

Leeds, , United Kingdom

Novara, , Italy

Merida, , Mexico

Petaling Jaya, , Malaysia

Fountain Valley, California, United States

Cooper City, Florida, United States

Brasília, , Brazil

São Paulo, , Brazil

São Paulo, , Brazil

Johor Bahru, , Malaysia

Kota Kinabalu, , Malaysia

Warszawa, , Poland

Sao Paulo, , Brazil

Tlajomulco De Zúñiga, , Mexico

Botucatu, , Brazil

Niteroi, , Brazil

Cooper City, Florida, United States

Mansoura, , Egypt

São José Do Rio Preto, , Brazil

Sao Jose Do Rio Preto, , Brazil

Goiânia, , Brazil

Recife, , Brazil

Mexico, , Mexico

Mexico, , Mexico

Ciudad De Mexico, , Mexico

Gainesville, Florida, United States

Gainesville, Florida, United States

Saint Petersburg, Florida, United States

Praha 2, , Czechia

Merriam, Kansas, United States

Sao Paulo, , Brazil

Sao Jose Do Rio Preto, , Brazil

Monza, , Italy

Barcelona, , Spain

Kansas City, Missouri, United States

Niterói, , Brazil

Rennes, , France

Kiryat Tzanz, , Israel

Ascoli Piceno, , Italy

Catania, , Italy

Amsterdam, , Netherlands

Roma, , Italy

Kanagawa, , Japan

Brasilia, , Brazil

Campinas, , Brazil

Recife, , Brazil

Santo Andre, , Brazil

Cairo, , Egypt

Cairo, , Egypt

Wakayama, , Japan

Budapest, , Hungary

Sendai, , Japan

Kanagawa, , Japan

Toyama, , Japan

Sao Paulo, , Brazil

Beijing Shi, , China

Hangzhou, , China

Barcelona, , Spain

Córdoba, , Spain

Suita, , Japan

łódź, , Poland

Málaga, , Spain

Cleveland, Ohio, United States

Katowice, , Poland

Santo Andre, , Brazil

Málaga, , Spain

Sao Jose Do Rio Preto, , Brazil

Sao Paulo, , Brazil

Fukushima, , Japan

Lodz, , Poland

Salvador, , Brazil

Sao Paulo, , Brazil

Athens, , Greece

Patients applied

0 patients applied

Trial Officials

Janssen Research & Development, LLC Clinical Trial

Study Director

Janssen Research & Development, LLC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials